DE

Dr. Henning Mennenöh, LL.M.

Rechtsanwalt, Partner
2024_03_11_rechtsanwaelte_nucleus_0849.jpg

For more than 20 years, Henning Mennenöh has been advising national and international pharma-, biotechnology-, diagnostic and medical technology companies of all sizes on industry specific agreements and M&A transactions in the Life Sciences sector.

Focus Areas

  • Research and Development Agreements

  • Clinical Trial Agreements, CRO Agreements

  • Master Services Agreements

  • Process Development Agree­ments and Technology Transfer Agree­ments

  • Contract Manufacturing Agreements and Quality Agreements

  • Collaboration Agreements

  • License Agreements

  • Strategic Alliances

  • Supply, Distribution, Warehousing and Logistics Agreements

  • Consultancy Agreements

  • Confidentiality Agreements

  • Material Transfer Agreements

  • University Collaborations

  • Industry specific support in M&A transactions, including due diligence reviews in the Life Sciences sector

Education and Experience

  • Study of Law at the University of Bonn (Germany), Université de Lausanne (Switzerland) and University of Illinois at Urbana-Champaign (USA)

  • Research Assistant at the Institute for Private International Law and  Comparative Law of the University of Bonn

  • Practice as lawyer in large international law firms, including as a Partner at Clifford Chance, Allen & Overy and Hogan & Hartson

  • Partner at Weitnauer Rechtsanwälte

  • Since 2024 Partner at nucleus partners Rechtsanwälte

Projects (selection)

  • Advised a leading German global pharma company on numerous agreements relating to research and development, clinical trials, contract manufacturing and various other cooperations.

  • Advised leading US global pharma and biotech companies on M&A, collaboration and contract manufacturing projects.

  • Advised a leading German pharma company on various M&A, collaboration and contract manufacturing projects.

  • Advised a German pharma company on the acquisition of a business unit from a Japanese group of companies.

  • Advised many German and foreign pharma and biotech companies on contract manufacturing agreements.

  • Advised various leading contract manufacturers from Germany and other countries on contract manufacturing agreements.

  • Advised numerous German and foreign biotech companies on international Master Service Agreements, License Agreements, Collaboration Agreements, Consulting Agreements and other industry specific agreements.

  • Advised many German and foreign pharma and biotech companies on clinical trial agreements, clinical services agreements with CROs and similar agreements.

  • Advised a leading German medtech company on a supply agreement with a US group of companies.

  • Advised small and medium-sized German medtech companies on international supply, service and distribution agreements.

  • Advised German and foreign pharma and biotech companies on license and collaboration projects with universities in the US.  

  • Advised various German and foreign pharma and biotech companies on the preparation of templates for industry specific agreements, for instance in the area of contract manufacturing.

Publications (selection)

  • Lohnherstellungsvertrag, Bromm/Thiermann/Mennenöh/Moers  in: Stief/Bromm (editors), Vertragshandbuch Pharma und Life Sciences, 2nd edition 2021

  • Handbuch Life Sciences Agreements in Germany, Weitnauer/Mennenöh (editors), 1st edition 2014

  • Lohnherstellungsverträge in der pharmazeutischen Industrie, Mennenöh/ Bergmann, Arzneimittel & Recht, 2/2014, p. 65

  • Unternehmenskaufverträge im Pharmabereich, Mennenöh, Arzneimittel & Recht, 1/2014, p. 3

  • Patente bei Kooperationen mit Industriepartnern, Mennenöh, VC-Magazin „Tech-Guide 2011“, p. 38

  • Fallstricke bei Finanzierungsrunden - Reichweite von Investmentschutzklauseln, Mennenöh,

  • GoingPublic „Biotechnologie 2008“, Sonderbeilage 2008, p. 134

  • M&A im Rahmen einer Finanzierungsrunde im Life Science-Bereich, Mennenöh, VC-Magazin, 3/2008, p. 34

  • Neue M&A-Transaktionsstrukturen: Perspektiven der Biotech-Industrie, Mennenöh, Pharm. Ind. 69, Nr.9/2007, p. 1024

  • Innovative Finanzierungen - Venture Debt für Biotech-Unternehmen, Mennenöh, GoingPublic „Biotechnologie 2007“, Sonderbeilage 2007, p. 140

  • Life Sciences Deals: Kooperation oder Akquisition?, Mennenöh, GoingPublic “Biotechnologie 2006”, Sonderbeilage 2006, p. 116

  • When Insolvency Strikes - How to Protect Licenses, Mennenöh/Plesser, Scrip Magazine April 2006, p.36

  • Unlocking Germany’s Potential, Mennenöh/Kircher, Pharmaceutical Contractor, January 2006, p.15

  • Gestaltungsfragen bei Lohnherstellungsverträgen, Mennenöh/Kircher, Pharm. Ind. 68, Nr. 7/2006, p. 849

P +49 89 205 008 5012
M +49 151 523 203 54